*** Disclaimer: This Database is still undergoing update on daily basis to prevent errors, discrepancies, and missing records. Please Contact FDIC@nafdac.gov.ng for enquires ***

Product Details

TREVICTA 263 mg prolonged release suspension for injection

Paliperidone palmitate
263mg
Suspension for injection

ROA

Intramuscular

Applicant Name

J & J Company West Africa Limited

NRN

A4-100553

Status

Active


ATC Code

N05AX13  

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)  

Packsize

1 X 1  

Product Description

48 NF-PP-268959 TREVICTA 263 mg prolonged release suspension for injection Paliperidone palmitate Each TREVICTA 263 mg pre filled syringe contains 410 mg paliperidone palmitate The other ingredients are: Polysorbate 20 Polyethylene glycol 4000 Citric acid monohydrate Sodium dihydrogen phosphate monohydrate Sodium hydroxide (for pH adjustment) Water for injections A4-100553 Drugs Imported Products 1*1 Prescription Only Medicine (POM) 7/17/2023 J & J COMPANY WEST AFRICA LIMITED, SINARI DARANIJO STREET, VICTORIA ISLAND LAGOS LAGOS 9062881239 uugwulek@its.jnj.com JANSSEN PHARMACEUTICA N.V, TURNHOUTSEWEG 30, B-2340 BEERSE, BELGIUM, Belgium

Manufacturer Name

Janssen Pharmaceutica NV

Manufacturer Country

BELGIUM  

Approval Date

2023-10-31  

Expiry Date

2028-10-30